By Katherine Hamilton
Shares of Hyperfine slipped after the health-technology company said it had commenced an underwritten public offering and shared preliminary third-quarter results.
The stock slid 17%, to $1.82, in after-hours trading Wednesday. Through the close, shares had more than doubled this year.
The company plans to offer Class A stock and pre-funded warrants to purchase stock, it said. It will grant underwriters a 30-day option to purchase up to 15% of the total number of securities sold in the offering.
The Guilford, Conn., company also shared preliminary results for the third quarter. It expects to record $3.4 million in revenue, which would be just below the $3.5 million analysts expect, according to FactSet.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
October 15, 2025 18:42 ET (22:42 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.